Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M468Revenue $M42.2Net Margin (%)39.4Z-Score13.7
Enterprise Value $M354EPS $0.8Operating Margin %-31.8F-Score5
P/E(ttm))18.1Cash Flow Per Share $0Pre-tax Margin (%)39.5Higher ROA y-yY
Price/Book3.810-y EBITDA Growth Rate %0Quick Ratio6.2Cash flow > EarningsN
Price/Sales8.35-y EBITDA Growth Rate %0Current Ratio6.3Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)11.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)13.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M20.3ROI % (ttm)21.6Gross Margin Increase y-yN

Gurus Latest Trades with HPTX

Number of guru portfolios checked: 56.

No Entry found!

HPTX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


HPTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Scharschmidt Bruce FrederickSVP & Chief Medical Officer 2014-07-02Sell200$28-17.54 view
SANDELL SCOTT D10% Owner 2014-06-06Sell1,430$5.54316.79 view
DRANT RYAN D10% Owner 2014-06-06Sell1,134$26.9-14.16 view
BARRETT M JAMES10% Owner 2014-06-06Sell1,430$26.88-14.1 view
BASKETT FOREST10% Owner 2014-06-06Sell1,377$26.9-14.16 view
BARRIS PETER J10% Owner 2014-06-06Sell1,134$26.9-14.16 view
KOLLURI KRISHNA KITTU10% Owner 2014-06-06Sell120$27.19-15.08 view
SOFINNOVA VENTURE PARTNERS VII10% Owner 2014-06-04Sell417,747$27.7-16.64 view
HEALY JAMESDirector 2014-06-04Sell417,747$27.7-16.64 view
Nash Christine ASVP & Chief Commercial Officer 2014-03-06Sell5,100$29.05-20.52 view

Press Releases about HPTX :

    Quarterly/Annual Reports about HPTX:

    News about HPTX:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    HYPERION THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation... Jul 21 2014
    HYPERION THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers Jul 08 2014
    Hyperion's Ravicti Submission Accepted in EU Jun 26 2014
    Hyperion says EMA to review of marketing authorization application for RAVICTI Jun 25 2014
    Hyperion Therapeutics Announces EMA Acceptance for Review of Marketing Authorization Application for... Jun 25 2014
    Hyperion Therapeutics to Present at the JMP Healthcare Conference Jun 18 2014
    HYPERION THERAPEUTICS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... Jun 13 2014
    Hyperion Therapeutics to Present at 2014 Wells Fargo Healthcare Conference Jun 12 2014
    Hyperion Therapeutics Completes Acquisition of Andromeda Biotech, Ltd. Jun 12 2014
    Hyperion (HPTX) in Focus: Stock Tumbles 9.5% Jun 09 2014
    HYPERION THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure Jun 06 2014
    Hyperion Therapeutics Announces Health Canada Accepts RAVICTI(R) New Drug Submission With Priority... Jun 03 2014
    Hyperion Therapeutics to Present at Jefferies 2014 Global Healthcare Conference May 28 2014
    HYPERION THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 28 2014
    HYPERION THERAPEUTICS INC Financials May 16 2014
    HYPERION THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report May 07 2014
    Hyperion Therapeutics to Present at Bank of America Merrill Lynch 2014 Health Care Conference May 07 2014
    Hyperion Therapeutics' (HPTX) CEO Don Santel on Q1 2014 Results - Earnings Call Transcript May 07 2014
    HYPERION THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 06 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide